𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer

✍ Scribed by PedroF. Escobar; Maurie Markman; Kristine Zanotti; Kenneth Webster; Jerome Belinson

Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
159 KB
Volume
129
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I study of pegylated liposomal dox
Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies
✍ Paula M. Fracasso; Kristie A. Blum; Benjamin R. Tan; Carole L. Fears; Nancy L. B πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and gemcitabine have single‐agent activity in breast and ovarian carcinoma patients. We conducted a Phase I trial to evaluate the maximum tolerated dose (MTD) and toxicities of this combination in patients with advanced malignancie